BioCardia, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
BioCardia, Inc. (BCDA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 0 shares for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-10-17.
Discontinued › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2016-10-17
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2016-09-30 was 0.00 shares.
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2016-06-30 was 0.00 shares.
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2016-03-31 was 0.00 shares.
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2015-12-31 was 0.00 shares.
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2015 was 0.00 shares.
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2014 was 0.00 shares.
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2013 was 0.00 shares.
- BioCardia, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2012 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month |
|---|---|---|---|---|
| 2016-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-17 | 0.00 shares derived: sum of 2 quarters · filed 2016-10-17 | 0.00 shares 10-Q · filed 2016-10-17 | 0.00 shares derived: sum of 4 quarters · filed 2016-10-17 |
| 2016-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | 0.00 shares 10-Q · filed 2016-08-02 | 0.00 shares derived: sum of 3 quarters · filed 2016-08-02 | 0.00 shares derived: sum of 4 quarters · filed 2016-08-02 |
| 2016-03-31 | 0.00 shares 10-Q · filed 2016-05-03 | 0.00 shares derived: sum of 2 quarters · filed 2016-05-03 | 0.00 shares derived: sum of 3 quarters · filed 2016-05-03 | 0.00 shares derived: sum of 4 quarters · filed 2016-05-03 |
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | 0.00 shares derived: sum of 2 quarters · filed 2016-03-25 | 0.00 shares derived: sum of 3 quarters · filed 2016-03-25 | 0.00 shares 10-K · filed 2016-03-25 |
| 2015-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | 0.00 shares derived: sum of 2 quarters · filed 2015-10-29 | 0.00 shares 10-Q · filed 2015-10-29 | 0.00 shares derived: sum of 4 quarters · filed 2016-03-25 |
| 2015-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | 0.00 shares 10-Q · filed 2015-08-12 | 0.00 shares derived: sum of 3 quarters · filed 2016-03-25 | 0.00 shares derived: sum of 4 quarters · filed 2016-03-25 |
| 2015-03-31 | 0.00 shares 10-Q · filed 2015-05-12 | 0.00 shares derived: sum of 2 quarters · filed 2016-03-25 | 0.00 shares derived: sum of 3 quarters · filed 2016-03-25 | 0.00 shares derived: sum of 4 quarters · filed 2016-03-25 |
| 2014-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | 0.00 shares derived: sum of 2 quarters · filed 2016-03-25 | 0.00 shares derived: sum of 3 quarters · filed 2016-03-25 | 0.00 shares 10-K · filed 2016-03-25 |
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | 0.00 shares derived: sum of 2 quarters · filed 2014-11-06 | 0.00 shares 10-Q · filed 2014-11-06 | 0.00 shares derived: sum of 4 quarters · filed 2014-11-06 |
| 2014-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | 0.00 shares 10-Q · filed 2014-08-06 | 0.00 shares derived: sum of 3 quarters · filed 2014-08-06 | 0.00 shares derived: sum of 4 quarters · filed 2014-08-06 |
| 2014-03-31 | 0.00 shares 10-Q · filed 2014-05-12 | 0.00 shares derived: sum of 2 quarters · filed 2014-05-12 | 0.00 shares derived: sum of 3 quarters · filed 2014-05-12 | 0.00 shares derived: sum of 4 quarters · filed 2014-05-12 |
| 2013-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-24 | 0.00 shares derived: sum of 2 quarters · filed 2014-03-24 | 0.00 shares derived: sum of 3 quarters · filed 2014-03-24 | 0.00 shares 10-K · filed 2014-03-24 |
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | 0.00 shares derived: sum of 2 quarters · filed 2013-11-01 | 0.00 shares 10-Q · filed 2013-11-01 | 0.00 shares derived: sum of 4 quarters · filed 2014-03-24 |
| 2013-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-26 | 0.00 shares 10-Q · filed 2013-07-26 | 0.00 shares derived: sum of 3 quarters · filed 2014-03-24 | 0.00 shares derived: sum of 4 quarters · filed 2014-03-24 |
| 2013-03-31 | 0.00 shares 10-Q · filed 2013-05-10 | 0.00 shares derived: sum of 2 quarters · filed 2014-03-24 | 0.00 shares derived: sum of 3 quarters · filed 2014-03-24 | |
| 2012-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-24 | 0.00 shares derived: sum of 2 quarters · filed 2014-03-24 | 0.00 shares 10-K · filed 2014-03-24 | |
| 2012-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | 0.00 shares 10-Q · filed 2012-11-08 | ||
| 2012-06-30 | 0.00 shares 10-Q · filed 2012-08-10 | |||
| 2011-12-31 | 0.00 shares 10-K · filed 2013-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |